Opening of Bids - Momentum TIF Project - Site Work Rebid Proj No 124-018R - Premium Concrete Services

Home Browse Search

Random testing will occur on a quarterly basis. Prior to selection, the DER shall ensure that the random testing pool has been updated to include all current covered employees in the Company's workforce. The number of tests to be conducted will be based on the number of covered employees at the beginning of each quarter's test cycle. The DER, or C/TPA, shall use the random selection procedures to compile a list of covered employees selected for testing in each testing cycle. The number of employees selected shall be sufficient to assure that the minimum number of required tests can be achieved. The list of employees selected will be retained by the DER in a secure location until the time of testing when the list will be provided to the appropriate division manager, department head, or supervisor who will, in turn, notify the employee(s) to report for testing. Random testing is unannounced, with employees being notified that they have been selected for testing after they have reported for duty on the day of collection. Specimen collection will be conducted on different days of the week throughout each test cycle to prevent employees from matching their drug use patterns to the schedule for collection. Random tests are normally unobserved by the collector. However, provisions will be available at the collection site for a directly observed collection to take place should circumstances require such action. Once notified by the appropriate Company official, employees will be instructed to report immediately to the collection site. Reasonable Suspicion/Cause Testing. The Company will conduct reasonable suspicion testing, also known as reasonable cause testing, based on the Company's observation of "signs and symptoms" of specific, contemporaneous, articulable observations concerning the appearance, behavior, speech or body odors of the employee. At least two Company supervisors, one of whom is trained in detection of the possible signs and symptoms of drug use, shall substantiate and concur in the decision to test an employee. The concurrence between the two supervisors may be by telephone. If the Company has 50 or fewer employees subject to testing under PHMSA regulations, only one supervisor, trained in detecting possible drug use signs and symptoms, is needed to make the decision to test. The supervisor making the determination to test shall document, in writing, the behavioral signs and symptoms that support the determination to conduct a reasonable suspicion/cause test. This documentation of the employee's conduct shall be prepared and signed within 24 hours of the observed behavior or before the results of the test are released, whichever is earlier. Refer to Appendix G: Reasonable Cause/Suspicion Observation Checklist. The potentially affected employee should not be allowed to proceed alone to or from the collection site. In addition to the safety concerns for the employee, accompanying the employee also assures that there is no opportunity in route to the collection site for the employee to compromise the test through any method of tampering that could affect the outcome of the test results Reasonable suspicion/cause tests are normally unobserved by the collector. However, provisions will be available at the collection site for a directly observed collection to take place should circumstances require such action. The employee shall not perform a covered function pending the receipt of the drug test results. The emplovee should make arrangements to be transported home. The emplovee should be instructed not to drive any motor on driving, a supervisor should notify the proper local law enforcement authority that an employee believed to be Return -to -Duty Testing. The Company will conduct areturn-to-duty test prior to an employee returning to covered safety -sensitive duty following a DOT violation. When an employee has a DOT violation the employee cannot work again in any DOT covered safety -sensitive function until successfully completing the Substance Abuse Professional (SAP) return -to -duty requirements. Only after the SAP has reported to the Company that the employee s eligible to return to covered safety -sensitive duties is the Company authorized to return the employee to a covered function. However, whether or not to do so is a business decision of the Company, not the DOT. When the Company makes the decision to return the employee to covered safety -sensitive duty, the Company will initiate the order for the return -to -duty test. All return -to-duty tests will be conducted using direct -observation collection procedures. Premium Concrete Services, Inc.- PHMSA DRUG/ALCOHOL PLAN 20 C� NATIONFlI GOMPIIANCE MANAGEMENT SERVICE, I�IC. (hl(;M51201 � (update 2021). ire NCMS pla�i is Iha subject of a ro9l�lared copyright and Is proleded Iry ropynghl le�vs in iho U S. end eise�vnem All ngl�ls esuved